Status:
COMPLETED
Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This study is a retrospective cohort trial to assess the efficacy of remdesivir in hospitalized adult patients diagnosed with COVID-19. The study is a multicenter trial which will be carried out on di...
Detailed Description
COVID-19 is a respiratory disease caused by a new coronavirus (SARS-CoV-2) and causes significant morbidity and mortality. There is currently no approved treatment for the treatment of patients with C...
Eligibility Criteria
Inclusion
- Adult ≥ 18 years old.
- SARS-CoV-2 infection confirmed.
- Hospitalized patients who received at least one administration of remdesivir therapy outside of clinical trials
Exclusion
- Patients included in a clinical trial testing remdesivir as an investigational drug.
Key Trial Info
Start Date :
May 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 12 2020
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04365725
Start Date
May 5 2020
End Date
June 12 2020
Last Update
April 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Cochin
Paris, France, 75014